ethylcholine aziridinium has been researched along with Alzheimer Disease in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (31.03) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, YH; Choi, EK; Joo, SS; Kim, TM; Kim, YB; Park, D | 1 |
| Bachurin, SO; Lermontova, NN; Nikolaeva, NS; Serkova, TP; Shevtsova, EF; Van'kin, GI; Vasilieva, NA | 1 |
| Ban, YH; Cha, Y; Choi, EK; Guo, H; Jang, GY; Jang, SK; Jeong, HS; Joo, SS; Kim, YB; Lee, JY; Lee, SH; Park, D; Yeon, S | 1 |
| Chonpathompikunlert, P; Muchimapura, S; Wattanathorn, J | 1 |
| Kolyasnikova, KN; Nazarova, GA; Zolotov, NN | 1 |
| Bachurin, SO; Lermontova, NN; Mukhina, TV; Serkova, TP; Van'kin, GI | 1 |
| Dudas, B; Hanin, I; Rose, M; Wülfert, E | 1 |
| Cornelli, U; Dudas, B; Hanin, I; Rose, M | 1 |
| Potter, PE; Thorne, B | 1 |
| Kelly, RM; Stackman, RW; Walsh, TJ | 1 |
| Hörtnagl, H | 1 |
| Bardea, A; Brenneman, DE; Fridkin, M; Gozes, I; Reshef, A; Rubinraut, S; Zamostiano, R; Zhukovsky, S | 1 |
| Dong, XW; Shan, HY; Yu, FL | 1 |
| El Tamer, A; Hanin, I; Wülfert, E | 1 |
| Bartolomeo, AC; Boast, CA; Morris, H | 1 |
| Afanasiev, A; Bachurin, S; Beznosko, B; Lermontova, N; Mukhina, T; Oxenkrug, G; Serkova, T; Shevtzova, E; Vankin, G | 1 |
| Bachurin, SO; Lermontova, NN; Lukoyanov, NV; Lukoyanova, EA; Serkova, TP | 1 |
| Hiramatsu, M; Kameyama, T; Nabeshima, T; Yamatsu, T | 1 |
| Opello, KD; Walsh, TJ | 1 |
| Hanin, I | 1 |
| Arendash, GW; Meyer, EM; Mouton, PR | 1 |
| Brandeis, R; Dachir, S; Fisher, A; Heldman, E; Karton, I; Levy, A; Pittel, Z; Sapir, M | 1 |
| Fisher, A; Hanin, I | 1 |
| Iga, Y; Kawanishi, G; Mizobe, F; Nakahara, N | 1 |
| Ikeda, H; Okano, T; Yamashita, M; Yoshimura, K | 1 |
| Cuello, AC; Stephens, PH; Tagari, P | 1 |
| Lammers, AJ; Steinbusch, HW; Tonnaer, JA; Wieringa, JH | 1 |
| Jarrard, LE; Kant, GJ; Levy, A; Meyerhoff, JL | 1 |
| Abraham, DJ; Hanin, I; Mistry, JS | 1 |
4 review(s) available for ethylcholine aziridinium and Alzheimer Disease
| Article | Year |
|---|---|
Strategies to limit brain injury and promote recovery of function.
Topics: Alzheimer Disease; Animals; Aziridines; Brain Diseases; Choline; Hippocampus; Humans; Parasympathetic Nervous System; Receptors, GABA | 1994 |
Neuroplasticity, the aging brain, and Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Aziridines; Brain; Brain Tissue Transplantation; Choline; Gangliosides; Humans; Nerve Growth Factors; Neuronal Plasticity | 1992 |
Cholinergic toxins and Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Humans; Neurotoxins; Parasympathomimetics | 1992 |
Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
Topics: Aged; Aging; Aluminum; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Haplorhini; Hemicholinium 3; Humans; Neuromuscular Blocking Agents; Neurotoxins; Parasympathetic Nervous System; Scopolamine | 1986 |
25 other study(ies) available for ethylcholine aziridinium and Alzheimer Disease
| Article | Year |
|---|---|
Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Humans; Memory Disorders; Mice; Microglia; Neprilysin; Neural Stem Cells | 2023 |
Wave-Like Dose-Dependence of the Stimulating Effects of Dimebon on Cognition in a Wide Dose Range.
Topics: Alzheimer Disease; Animals; Aziridines; Biological Clocks; Central Nervous System Stimulants; Choline; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Maze Learning; Mice; Mice, Inbred C57BL; Pattern Recognition, Physiological; Rats; Rats, Wistar | 2019 |
A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Cell Line, Tumor; Choline; Choline O-Acetyltransferase; Cognition; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Insect Proteins; Male; Maze Learning; Peptide Fragments; Rats; Rats, Sprague-Dawley; Silk | 2017 |
Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Aziridines; Benzodioxoles; Choline; Cognition Disorders; Donepezil; Hippocampus; Indans; Injections, Intraventricular; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Nerve Degeneration; Neuromuscular Blocking Agents; Neuroprotective Agents; Nootropic Agents; Piper nigrum; Piperidines; Polyunsaturated Alkamides; Rats; Space Perception; Thailand | 2010 |
Changes in activity of proline-specific peptidases in rat model for dementia of Alzheimer's type.
Topics: Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Aziridines; Cerebral Cortex; Choline; Dipeptidyl Peptidase 4; Hippocampus; Male; Prolyl Oligopeptidases; Rats; Rats, Wistar; Reaction Time; Scopolamine; Serine Endopeptidases; Statistics, Nonparametric | 2012 |
Comparison of the effect of NT-0409 and antidementia drugs on learning and memory in rats with chronic cerebral cholinergic deficiency.
Topics: Alzheimer Disease; Animals; Aziridines; Brain; Choline; Excitatory Amino Acid Agonists; Male; Maze Learning; Memantine; Memory; Rats; Rats, Wistar; Receptors, AMPA | 2003 |
Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aziridines; Cell Death; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Dehydroepiandrosterone; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Immunohistochemistry; Male; Nerve Degeneration; Neuroglia; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Inbred F344; Septal Nuclei; tau Proteins | 2004 |
Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Aziridines; Cell Death; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Glycosaminoglycans; Heparinoids; Hippocampus; Male; Neuroprotective Agents; Neurotoxins; Rats; Rats, Inbred F344 | 2004 |
Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Choline; Disease Models, Animal; Electric Stimulation; Hippocampus; In Vitro Techniques; Injections, Intraventricular; Male; Neurotoxins; Nicotine; Oxotremorine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Stimulation, Chemical | 1995 |
AF64A-induced brain damage and its relation to dementia.
Topics: Acetylcholine; Alzheimer Disease; Animals; Aziridines; Brain Damage, Chronic; Choline; Choline O-Acetyltransferase; Corticosterone; Feedback; Female; Glucocorticoids; Glutamic Acid; Hippocampus; Humans; Male; Neuromuscular Blocking Agents; Neurotoxins; Neurotransmitter Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Sex Characteristics; Somatostatin; Synaptic Vesicles | 1994 |
Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide.
Topics: Administration, Intranasal; Alzheimer Disease; Amyloid beta-Peptides; Animals; Aziridines; Cell Death; Cells, Cultured; Choline; Learning; Lipids; Male; Memory; Neuromuscular Blocking Agents; Neurons; Parasympatholytics; Rats; Rats, Wistar; Solubility; Structure-Activity Relationship; Vasoactive Intestinal Peptide | 1996 |
[Effects of AF64A on neurons containing both nitric oxide synthase and choline acetyltransferase in the rat septal complex].
Topics: Alzheimer Disease; Animals; Aziridines; Choline; Choline O-Acetyltransferase; Hippocampus; Male; Neurons; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Septal Nuclei | 1996 |
Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
Topics: Acetylcholinesterase; Aging; Alzheimer Disease; Animals; Aziridines; Choline; Choline O-Acetyltransferase; Cholinergic Antagonists; Cholinergic Fibers; Disease Models, Animal; Enzyme Induction; Hippocampus; Injections, Intraventricular; Male; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Septum Pellucidum | 1996 |
Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Arecoline; Aziridines; Brain; Brain Mapping; Cerebral Cortex; Choline; Disease Models, Animal; Dose-Response Relationship, Drug; Hippocampus; Infusion Pumps, Implantable; Male; Maze Learning; Mental Recall; Muscarinic Agonists; Neurotoxins; Rats; Rats, Sprague-Dawley; Retention, Psychology | 1997 |
N-acetylserotonin, melatonin and their derivatives improve cognition and protect against beta-amyloid-induced neurotoxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning; Aziridines; Cells, Cultured; Cerebellum; Choline; Cognition; Drug Evaluation, Preclinical; Male; Melatonin; Neuromuscular Blocking Agents; Nootropic Agents; Rats; Rats, Wistar; Serotonin | 1999 |
Dimebon improves learning in animals with experimental Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Choline; Cholinesterase Inhibitors; Disease Models, Animal; Histamine H1 Antagonists; Indoles; Injections, Intraventricular; Male; Neuromuscular Blocking Agents; Rats; Rats, Wistar; Tacrine | 2000 |
Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
Topics: Acetylcholine; Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Motor Activity; Neuromuscular Blocking Agents; Neuroprotective Agents; Nicotine; Rats; Rats, Sprague-Dawley | 2002 |
Intracortical AF64A: memory impairments and recovery from cholinergic hypofunction.
Topics: Acetylcholine; Alzheimer Disease; Animals; Avoidance Learning; Aziridines; Biological Transport; Cerebral Cortex; Choline; Disease Models, Animal; Memory; Rats; Rats, Inbred Strains; Time Factors | 1989 |
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3') quinuclidine (AF102B): a new M1 agonist attenuates cognitive dysfunctions in AF64A-treated rats.
Topics: Alzheimer Disease; Animals; Aziridines; Behavior, Animal; Choline; Cognition Disorders; Disease Models, Animal; Drug Design; Male; Molecular Structure; Parasympathomimetics; Quinuclidines; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Thiophenes | 1989 |
Effects of intracerebroventricular injection of AF64A on learning behaviors in rats.
Topics: Alzheimer Disease; Amnesia; Animals; Avoidance Learning; Aziridines; Azirines; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Hippocampus; Injections, Intraventricular; Learning; Male; Physostigmine; Rats; Rats, Inbred Strains | 1988 |
Neurochemical effects following AF64A injection into the basal nuclei of rats.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Aziridines; Azirines; Basal Ganglia; Choline; Choline O-Acetyltransferase; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Neural Pathways; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains; Septal Nuclei; Substantia Innominata | 1987 |
Ethylcholine mustard aziridinium ion lesions of the rat cortex result in retrograde degeneration of basal forebrain cholinergic neurons: implications for animal models of neurodegenerative disease.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Basal Ganglia; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Male; Nerve Degeneration; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Retrograde Degeneration; Substantia Innominata | 1987 |
Immunohistochemical evidence for degeneration of cholinergic neurons in the forebrain of the rat following injection of AF64A-picrylsulfonate into the dorsal hippocampus.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Choline; Choline O-Acetyltransferase; Cholinergic Fibers; Diencephalon; Disease Models, Animal; Hippocampus; Rats; Rats, Inbred Strains; Serotonin; Telencephalon; Trinitrobenzenesulfonic Acid | 1986 |
Intracerebral injections of AF64A: an animal model of Alzheimer's disease?
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Brain; Choline; Cholinergic Fibers; Disease Models, Animal; Humans; Injections, Intraventricular; Mental Recall; Neuromuscular Blocking Agents; Rats | 1985 |
Neurochemistry of aging. 1. Toxins for an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Aziridines; Azirines; Binding, Competitive; Biological Transport; Brain Chemistry; Choline; Disease Models, Animal; In Vitro Techniques; Mice; Models, Molecular; Parasympathetic Nervous System; Quinuclidinyl Benzilate; Receptors, Muscarinic; Structure-Activity Relationship; Synaptosomes; Toxins, Biological | 1986 |